The path(way) less traveled

Research output: Contribution to journalArticlepeer-review


In this issue of Blood, Mathewson et al characterized targeting a novel intracellular pathway with an agent known to induce potent antitumor effects but now also appears to potently suppress inflammatory responses by dendritic cells (DCs) and prevent graft-vs-host disease (GVHD). Identifying agents that can suppress GVHD yet not compromise graft-vs-tumor (GVT) effects remains a paramount goal in allogeneic hematopoietic stem cell transplantation (HSCT).

Original languageEnglish (US)
Pages (from-to)1996-1997
Number of pages2
Issue number12
StatePublished - Sep 19 2013

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology


Dive into the research topics of 'The path(way) less traveled'. Together they form a unique fingerprint.

Cite this